# REMODULIN
> **NDA208276** · New Drug Application · Sponsor: UNITED THERAP · Approved 2018-07-30
## Drug
- **FDA Application Number:** NDA208276
- **Application type:** New Drug Application
- **Brand name:** REMODULIN
- **Generic name:** Treprostinil
- **Active ingredients:** TREPROSTINIL
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS, SUBCUTANEOUS
- **Marketing status:** Discontinued
- **Sponsor:** UNITED THERAP
- **First approval:** 2018-07-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208276)
---
*AI Analytics · CC0 1.0*